AI system boosts intracranial hemorrhage detection

Improving the detection of intracranial hemorrhage (ICH) on CT scans has been somewhat of an Achilles heel for artificial intelligence tools, but the authors of a new study believe they may have found the golden ticket with a deep learning system that does indeed boost the detection of ICH. 

The system is Caire ICH, and in an analysis that included more than 500 CT scans, its use improved radiologist performance across a number of metrics. 

“Though algorithms have been constructed to evaluate scans for the presence of an ICH, they treat ICH as a homogenous pathology, when in fact various subtypes of ICH are observed and often managed in differing ways,” corresponding author of the study Gabriel Neves, MD, of the Texas Tech University Health Sciences Center, and colleagues explained. 

Specifically, the system improved inter-reader agreement by an average of 5.76% in a dataset with an ICH prevalence of 74.3%. Accuracy, sensitivity and specificity all increased by 6.15, 4.6 and 10.62%, respectively. Compared to interpretations completed without the use of the system, radiologists were said to detect an additional 18 ICHs on average, while also improving their identification of different ICH subtypes when the tool was utilized

The authors noted that in a reading environment that is subject to increasingly burdensome workloads for radiologists, the likelihood of interpretation errors and missed findings increases. This is especially true in the instances of ICH, which can be deadly for patients. Having tools available to enhance detection is beneficial for all involved, they suggested. 

“This study implies that future clinical workflows may see AI be used in an adjunct capacity to improve interpretations of CT scans by helping call radiologists' attention to findings that may be overlooked.” 

The detailed study can be viewed in Cureus

 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.